Robert Coleman Selected Research

Robert Coleman Research Topics

Disease

65	Breast Neoplasms (Breast Cancer) 03/2024 - 04/2004
41	Neoplasms (Cancer) 03/2024 - 03/2005
35	Neoplasm Metastasis (Metastasis) 05/2023 - 10/2004
14	Prostatic Neoplasms (Prostate Cancer) 04/2019 - 10/2004
12	Bone Diseases (Bone Disease) 10/2021 - 10/2004
10	Pain (Aches) 01/2023 - 10/2004
7	Osteonecrosis (Kienbock's Disease) 04/2022 - 01/2011
5	Bone Resorption 01/2018 - 01/2006
4	Fatigue 12/2023 - 01/2014
4	Multiple Myeloma 04/2022 - 10/2007
3	Neutropenia 01/2020 - 01/2017
3	Human Influenza (Influenza) 01/2019 - 02/2015
3	Vomiting 01/2017 - 04/2008
3	Infections 01/2017 - 01/2014
3	Nausea 01/2017 - 04/2008
3	Osteolysis 09/2009 - 01/2006
3	Spontaneous Fractures (Pathological Fracture) 10/2007 - 03/2005
2	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 01/2022
2	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 03/2005
2	Carcinoma (Carcinomatosis) 01/2022 - 02/2013
2	Osteoporosis 11/2018 - 01/2018
2	Arthralgia (Joint Pain) 01/2017 - 01/2014
2	Myalgia 01/2017 - 01/2011
2	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2016 - 12/2012
2	Fever (Fevers) 02/2015 - 01/2011
2	Chronic Renal Insufficiency 02/2013 - 08/2007
2	Disease Progression 08/2007 - 06/2006
1	Triple Negative Breast Neoplasms 12/2023
1	Carcinosarcoma 01/2023
1	Fibrosarcoma 07/2022
1	Femoral Fractures (Femoral Fracture) 04/2022
1	Hypocalcemia 04/2022

Drug/Important Bio-Agent (IBA)

26	Diphosphonates (Bisphosphonates)IBA 03/2024 - 10/2004
20	Zoledronic Acid (Zometa)FDA Link 03/2024 - 06/2006
15	Hormones (Hormone)IBA 01/2020 - 12/2005
14	Denosumab FDA Link 05/2023 - 10/2007
14	Biomarkers (Surrogate Marker)IBA 05/2023 - 03/2004
9	Aromatase InhibitorsIBA 11/2018 - 04/2005
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 06/2005
5	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 06/2005
5	Tamoxifen FDA LinkGeneric 11/2018 - 01/2007
5	Docetaxel (Taxotere)FDA Link 06/2014 - 06/2005
4	Epirubicin (Ellence)FDA LinkGeneric 12/2023 - 05/2009
4	Estrogen ReceptorsIBA 09/2021 - 08/2013
4	Ibandronic Acid (Boniva)FDA Link 11/2020 - 10/2004
4	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2007
4	Monoclonal AntibodiesIBA 01/2020 - 01/2007
4	exemestane (Aromasin)FDA Link 07/2018 - 08/2013
4	AnthracyclinesIBA 01/2017 - 04/2008
4	taxaneIBA 01/2017 - 04/2008
4	Radium-223IBA 03/2016 - 06/2014
3	Capecitabine (Xeloda)FDA Link 12/2023 - 04/2008
3	Maf Transcription FactorsIBA 05/2023 - 12/2015
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2020
3	VaccinesIBA 01/2019 - 02/2015
3	CalciumIBA 01/2018 - 06/2014
3	Prostate-Specific Antigen (Semenogelase)IBA 02/2015 - 08/2007
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2012 - 01/2006
3	CytokinesIBA 07/2012 - 01/2006
2	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 01/2017
2	pembrolizumabIBA 01/2023 - 01/2022
2	lenvatinibIBA 01/2023 - 01/2022
2	AntigensIBA 12/2022 - 02/2015
2	PlatinumIBA 01/2022 - 08/2007
2	Anastrozole (Arimidex)FDA LinkGeneric 01/2021 - 04/2004
2	Pamidronate (Aredia)FDA LinkGeneric 11/2020 - 10/2007
2	Clodronic Acid (Clodronate)IBA 11/2020 - 09/2009
2	human ERBB2 proteinIBA 01/2020 - 01/2020
2	pertuzumabIBA 01/2020 - 01/2018
2	AndrogensIBA 11/2018 - 06/2006
2	collagen type I trimeric cross-linked peptideIBA 01/2018 - 06/2006
2	Collagen Type I (Type I Collagen)IBA 01/2018 - 12/2011
2	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 03/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 06/2005
2	Taxoids (Taxanes)IBA 04/2008 - 07/2007
2	liposomal doxorubicin (Doxil)FDA Link 08/2007 - 01/2007
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2023
1	Bevacizumab (Avastin)FDA Link 12/2022
1	LigandsIBA 04/2022
1	Opioid Analgesics (Opioids)IBA 04/2022
1	NivolumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	cabozantinibIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2021
1	Celecoxib (Celebrex)FDA Link 09/2021
1	NitrogenIBA 11/2020

Therapy/Procedure

41	Therapeutics 03/2024 - 07/2004
17	Drug Therapy (Chemotherapy) 01/2023 - 07/2004
9	Adjuvant Chemotherapy 12/2023 - 07/2004
7	Castration 11/2018 - 06/2006
4	Radiotherapy 06/2014 - 08/2007
3	Neoadjuvant Therapy 12/2023 - 01/2018
3	Immunotherapy 01/2023 - 02/2015
3	Exercise Therapy (Therapy, Exercise) 09/2007 - 12/2004
2	Aftercare (After-Treatment) 06/2021 - 03/2007
2	Combination Drug Therapy (Combination Chemotherapy) 01/2013 - 01/2007
1	Length of Stay 01/2023
1	Precision Medicine 01/2023
1	Drug Tapering 10/2021
1	Injections 01/2021